Results of the first human study of a capsule designed to replace injections of biologics have been announced, using an automatic pill designed by Silicon Valley-based Rani Therapeutics.

Matt is currently Head of the Coverage Team at The Motley Fool. He has been a full-time Motley Fool employee since 2012 and is a former advisor and analyst for multiple Motley Fool services.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best Android tablets are better than ever, and as we've seen over years of testing the ...